AUTHORS' REPLY: We concur with Dr. Fortuna that this patient had an intraoral burning sensation with a probable association with clindamycin according to the Naranjo probability scale, 1 best described as clindamycin-induced oral burning. The patient was not clinically depressed at the time of his diagnosis of xerostomia and clindamycin-induced oral burning nor was his episode of prostatitis associated with depression. His prostatitis would not be expected to impact the oral burning.
It is pertinent to know whether this patient ever had a burning sensation or xerostomia during treatment with amoxicillin. He had received amoxicillin multiple times in the past but had never experienced a burning sensation or xerostomia associated with this antibiotic. Oral candidiasis can cause these symptoms, but an otolaryngologist determined that there was no evidence of candidiasis at the time of the patient's symptoms.
We used the term xerostomia to indicate a "dry mouth [that] is now commonly associated with certain medications" 2 and other disorders in accordance with common usage by the American Academy of Periodontology, American Dental Association, Academy of General Dentistry, American Pharmacists Association, and others. 3,4 This patient had xerostomia with subjective and objective evidence of hyposialia that resolved with pilocarpine, although his oral burning persisted.
We stand by the Naranjo probability scale indicating a probable association between clindamycin and this patient's intraoral burning, and clausula rebus sic stantibus does not apply.
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